BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22813883)

  • 1. Glycomics of pediatric and adulthood diseases of the central nervous system.
    Barone R; Sturiale L; Palmigiano A; Zappia M; Garozzo D
    J Proteomics; 2012 Sep; 75(17):5123-39. PubMed ID: 22813883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical glycomics for the diagnosis of congenital disorders of glycosylation.
    Abu Bakar N; Lefeber DJ; van Scherpenzeel M
    J Inherit Metab Dis; 2018 May; 41(3):499-513. PubMed ID: 29497882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycomics and glycoproteomics focused on aging and age-related diseases--Glycans as a potential biomarker for physiological alterations.
    Miura Y; Endo T
    Biochim Biophys Acta; 2016 Aug; 1860(8):1608-14. PubMed ID: 26801879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovation Analysis on Postgenomic Biomarkers: Glycomics for Chronic Diseases.
    Adua E; Russell A; Roberts P; Wang Y; Song M; Wang W
    OMICS; 2017 Apr; 21(4):183-196. PubMed ID: 28388299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycomics, glycoproteomics and the immune system.
    Kolarich D; Lepenies B; Seeberger PH
    Curr Opin Chem Biol; 2012 Apr; 16(1-2):214-20. PubMed ID: 22221852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyco-biomarkers: potential determinants of cellular physiology and pathology.
    Alavi A; Axford JS
    Dis Markers; 2008; 25(4-5):193-205. PubMed ID: 19126964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycomics: towards bioinformatic approaches to understanding glycosylation.
    Mahal LK
    Anticancer Agents Med Chem; 2008 Jan; 8(1):37-51. PubMed ID: 18220504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: Application to cerebrospinal fluid.
    Goyallon A; Cholet S; Chapelle M; Junot C; Fenaille F
    Rapid Commun Mass Spectrom; 2015 Mar; 29(6):461-73. PubMed ID: 26160412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of mouse and human immune cells: insights emerging from N-glycomics analyses.
    Antonopoulos A; North SJ; Haslam SM; Dell A
    Biochem Soc Trans; 2011 Oct; 39(5):1334-40. PubMed ID: 21936811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovering new clinical markers in the field of glycomics.
    Telford JE; Doherty MA; Tharmalingam T; Rudd PM
    Biochem Soc Trans; 2011 Jan; 39(1):327-30. PubMed ID: 21265797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycobiomarkers by glycoproteomics and glycan profiling (glycomics): emergence of functionality.
    Gabius HJ
    Biochem Soc Trans; 2011 Jan; 39(1):399-405. PubMed ID: 21265812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome.
    Tharmalingam T; Mariño K; Rudd PM
    Carbohydr Res; 2010 Jul; 345(10):1280-2. PubMed ID: 20447618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments and perspectives in high-throughput protein glycomics: enabling the analysis of thousands of samples.
    de Haan N; Pučić-Baković M; Novokmet M; Falck D; Lageveen-Kammeijer G; Razdorov G; Vučković F; Trbojević-Akmačić I; Gornik O; Hanić M; Wuhrer M; Lauc G;
    Glycobiology; 2022 Jul; 32(8):651-663. PubMed ID: 35452121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lectin microarrays for glycomic analysis.
    Gupta G; Surolia A; Sampathkumar SG
    OMICS; 2010 Aug; 14(4):419-36. PubMed ID: 20726799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy.
    Muthu M; Chun S; Gopal J; Anthonydhason V; Haga SW; Jacintha Prameela Devadoss A; Oh JW
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylation.
    Van Scherpenzeel M; Willems E; Lefeber DJ
    Glycoconj J; 2016 Jun; 33(3):345-58. PubMed ID: 26739145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unravelling Immunoglobulin G Fc N-Glycosylation: A Dynamic Marker Potentiating Predictive, Preventive and Personalised Medicine.
    Russell A; Adua E; Ugrina I; Laws S; Wang W
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29382131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable isotope labeling of N-glycosylated peptides by enzymatic deglycosylation for mass spectrometry-based glycoproteomics.
    Kaji H; Isobe T
    Methods Mol Biol; 2013; 951():217-27. PubMed ID: 23296533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics in glycomics.
    Soo EC; Hui JP
    Methods Mol Biol; 2010; 600():175-86. PubMed ID: 19882128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies.
    Zoldoš V; Horvat T; Lauc G
    Curr Opin Chem Biol; 2013 Feb; 17(1):34-40. PubMed ID: 23287290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.